Booth Bruce 的 Form 4/A 修正申報

修正

Kymera Therapeutics, Inc.（KYMR），2026/7/2 申報

申報編號: 0001451612-26-000022
申報時間: 2026/7/2 17:39 ET
交易日: 2026/6/29
申報延遲: 3 天
10b5-1 計畫: 有勾選
原始申報日: 2026/6/30

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 14 筆非衍生性交易。公開市場賣出合計 $828.2 萬。交易後 3 天申報。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Booth BruceCIK 0001451612	董事

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

非衍生性證券的交易
交易日	證券	交易	股數	價格	金額	交易後持股	持有方式
2026/6/29	Common Stock	S賣出處分	−5,549	$105.78^F3	−$586,973.22	2,446,375	間接
2026/6/29	Common Stock	S賣出處分	−14,798	$106.63^F5	−$1,577,910.74	2,431,577	間接
2026/6/29	Common Stock	S賣出處分	−19,419	$107.76^F6	−$2,092,591.44	2,412,158	間接
2026/6/29	Common Stock	S賣出處分	−10,848	$108.28^F7	−$1,174,621.44	2,401,310	間接
2026/6/29	Common Stock	S賣出處分	−7,968	$109.75^F8	−$874,488	2,393,342	間接
2026/6/29	Common Stock	S賣出處分	−7,723	$110.67^F9	−$854,704.41	2,385,619	間接
2026/6/29	Common Stock	S賣出處分	−934	$111.20^F10	−$103,860.8	2,384,685	間接
2026/6/29	Common Stock	S賣出處分	−770	$105.78^F3	−$81,450.6	471,497	間接
2026/6/29	Common Stock	S賣出處分	−2,133	$106.63^F5	−$227,441.79	469,364	間接
2026/6/29	Common Stock	S賣出處分	−2,698	$107.76^F6	−$290,736.48	466,666	間接
2026/6/29	Common Stock	S賣出處分	−1,498	$108.28^F7	−$162,203.44	465,168	間接
2026/6/29	Common Stock	S賣出處分	−1,104	$109.75^F8	−$121,164	464,064	間接
2026/6/29	Common Stock	S賣出處分	−1,078	$110.67^F9	−$119,302.26	462,986	間接
2026/6/29	Common Stock	S賣出處分	−130	$111.20^F10	−$14,456	462,856	間接

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.

The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.015 to $106.0145 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (3) and (5) through (10).

表 I 有 2 筆交易的價格引用這則附註。

These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.0271 to $106.96 inclusive.

表 I 有 2 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.03 to $108.0293 inclusive.

表 I 有 2 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.0326 to $109.019 inclusive.

表 I 有 2 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.034 to $109.96 inclusive.

表 I 有 2 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.09 to $111.08 inclusive.

表 I 有 2 筆交易的價格引用這則附註。

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.09 to $111.63 inclusive.

表 I 有 2 筆交易的價格引用這則附註。

F11

The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF"). Atlas Venture Associates Opportunity I, L.P. ("AVAO LP") is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any.

備註

This Amendment is being filed to address an inadvertent clerical error in the original Form 4 relating to the allocation of the reported sales between Atlas Venture Fund X and AVOF. The aggregate number of shares sold by Atlas Venture Fund X and AVOF, as reported in the original Form 4, remains unchanged.

看 SEC EDGAR 上的完整原文（在新分頁開啟）